Dr. Robert Bonwetsch, MD
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Years since graduation
- 28
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 667
Licensed in Connecticut since 2004, according to the Connecticut Department of Public Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
CT license 042914 (first issued 2004; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Danbury Hospital Danbury, CT
- Norwalk Hospital Norwalk, CT
Medical groups
- Nuvance Health Medical Practice Ct Inc (747 clinicians)
- Ptsma Inc (224 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 667
- Services billed
- 1,711
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 516 | 345 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 152 | 73 |
| New patient office or other outpatient visit, 45-59 minutes | 127 | 127 |
| Measurement of brain wave activity (eeg), awake and drowsy | 112 | 105 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 73 | 71 |
| Established patient office or other outpatient visit, 40-54 minutes | 60 | 58 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 26 | 16 |
| Critical care, first 30-74 minutes | 22 | 18 |
| Measurement of brain wave activity (eeg), 12-26 hours with health care professional review and report | 21 | 21 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 16 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $33,329 in research payments for these studies, mostly to the institutions running them.
- An Extension Study to Evaluate the Long-Term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's Disease
UCB SA · Terminated · NCT05543252 - A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease
UCB SA · Completed · NCT04658186
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.